BR9604808A - Ascomicinas - Google Patents

Ascomicinas

Info

Publication number
BR9604808A
BR9604808A BR9604808A BR9604808A BR9604808A BR 9604808 A BR9604808 A BR 9604808A BR 9604808 A BR9604808 A BR 9604808A BR 9604808 A BR9604808 A BR 9604808A BR 9604808 A BR9604808 A BR 9604808A
Authority
BR
Brazil
Prior art keywords
workshops
Prior art date
Application number
BR9604808A
Other languages
English (en)
Inventor
Rene Hersperger
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9507128.8A external-priority patent/GB9507128D0/en
Priority claimed from GBGB9526049.3A external-priority patent/GB9526049D0/en
Priority claimed from GBGB9526050.1A external-priority patent/GB9526050D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BR9604808A publication Critical patent/BR9604808A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
BR9604808A 1995-04-06 1996-04-04 Ascomicinas BR9604808A (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9507128.8A GB9507128D0 (en) 1995-04-06 1995-04-06 Organic compounds
GBGB9526049.3A GB9526049D0 (en) 1995-12-20 1995-12-20 Organic compounds
GBGB9526050.1A GB9526050D0 (en) 1995-12-20 1995-12-20 Organic compounds
PCT/EP1996/001492 WO1996031514A1 (en) 1995-04-06 1996-04-04 Ascomycins

Publications (1)

Publication Number Publication Date
BR9604808A true BR9604808A (pt) 1998-06-09

Family

ID=27267660

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9604808A BR9604808A (pt) 1995-04-06 1996-04-04 Ascomicinas

Country Status (21)

Country Link
US (1) US5925649A (pt)
EP (1) EP0819130A1 (pt)
JP (1) JP2000505044A (pt)
KR (1) KR19980703583A (pt)
CN (1) CN1088068C (pt)
AR (1) AR004480A1 (pt)
AU (1) AU703523B2 (pt)
BR (1) BR9604808A (pt)
CA (1) CA2216562A1 (pt)
CO (1) CO4750668A1 (pt)
CZ (1) CZ312397A3 (pt)
FI (1) FI973529A (pt)
HU (1) HUP9801993A3 (pt)
IL (1) IL117815A (pt)
MX (1) MX9707636A (pt)
NO (1) NO309273B1 (pt)
NZ (1) NZ307170A (pt)
PL (1) PL322553A1 (pt)
SK (1) SK133997A3 (pt)
TR (1) TR199700999T1 (pt)
WO (1) WO1996031514A1 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI235068B (en) 1998-03-26 2005-07-01 Fujisawa Pharmaceutical Co Sustained-release pharmaceutical composition
GB9826656D0 (en) * 1998-12-03 1999-01-27 Novartis Ag Organic compounds
US6121257A (en) * 1999-03-31 2000-09-19 Abbott Laboratories Sulfamate containing macrocyclic immunomodulators
BR0011225A (pt) * 1999-04-30 2002-03-19 Sucampo Ag Agente para tratar de olhos secos, seu método e uso
US7063857B1 (en) 1999-04-30 2006-06-20 Sucampo Ag Use of macrolide compounds for the treatment of dry eye
AU769315B2 (en) 1999-08-24 2004-01-22 Cellgate, Inc. Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties
AR033151A1 (es) * 2001-04-12 2003-12-03 Sucampo Pharmaceuticals Inc Agente para el tratamiento oftalmico topico de las enfermedades inflamatorias oculares
JP2005512946A (ja) * 2001-05-09 2005-05-12 ノバルティス アクチエンゲゼルシャフト 選択的免疫調節法
RU2005118750A (ru) * 2002-11-15 2006-03-20 Новартис АГ (CH) Органические соединения
WO2004071398A2 (en) * 2003-02-17 2004-08-26 Cipla Ltd Pharmaceutical patch
TWI324604B (en) * 2003-06-18 2010-05-11 Novartis Ag New use of staurosporine derivatives
US7780973B2 (en) * 2003-12-15 2010-08-24 Ethicon Endo-Surgery, Inc. Method and device for minimally invasive implantation of biomaterial
EP1699456A1 (en) * 2003-12-30 2006-09-13 Astellas Pharma Inc. Use of macrolides for treating or preventing airflow obstruction
US20050142161A1 (en) * 2003-12-30 2005-06-30 Freeman Lynetta J. Collagen matrix for soft tissue augmentation
WO2006082588A2 (en) * 2005-02-07 2006-08-10 Pharmalight Inc. Method and device for ophthalmic administration of active pharmaceutical ingredients
WO2016068208A1 (ja) 2014-10-28 2016-05-06 国立研究開発法人国立成育医療研究センター 妊娠状態を改善するための薬剤及びその利用
CN112533599A (zh) 2018-08-10 2021-03-19 山口晃史 与母体和胎儿的关系中的体液免疫相关的疾病的治疗药
JPWO2020129348A1 (ja) 2018-12-18 2021-11-04 晃史 山口 不妊・不育症または妊娠状態を改善するための薬剤

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3244592A (en) * 1962-06-09 1966-04-05 Arai Tadashi Ascomycin and process for its production
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
JPS6317884A (ja) * 1986-05-30 1988-01-25 Fujisawa Pharmaceut Co Ltd トリシクロ化合物
JPH01125394A (ja) * 1987-11-10 1989-05-17 Mect Corp シアロシルグリセロリピッド類及びその製造方法
EP0346427B1 (en) * 1987-12-09 1995-03-29 FISONS plc Macrocyclic compounds
WO1991002736A1 (en) * 1989-08-18 1991-03-07 Fisons Plc Macrocyclic compounds
KR0159766B1 (ko) * 1989-10-16 1998-12-01 후지사와 토모키치로 양모제 조성물
NZ235991A (en) * 1989-11-09 1993-05-26 Sandoz Ltd Macrolide compounds and pharmaceutical compositions thereof
WO1991013899A1 (en) * 1990-03-12 1991-09-19 Fujisawa Pharmaceutical Co., Ltd. Tricyclo compounds
EP0533930A1 (en) * 1990-06-11 1993-03-31 Fujisawa Pharmaceutical Co., Ltd. Use of a macrolide compound such as fk 506 for manufacturing a medicament for treating idiopathic thrombocytopenic purpura and basedow's disease
MY110418A (en) * 1990-07-02 1998-05-30 Novartis Ag Heteroatoms-containing tricyclic compounds.
ES2099112T3 (es) * 1990-09-04 1997-05-16 Fujisawa Pharmaceutical Co Pomadas que contienen un compuesto triciclico.
IE65341B1 (en) * 1990-11-08 1995-10-18 Fujisawa Pharmaceutical Co Suspensions containing tricyclic compounds
US5208241A (en) * 1991-09-09 1993-05-04 Merck & Co., Inc. N-heteroaryl, n-alkylheteroaryl, n-alkenylheteroaryl and n-alkynylheteroarylmacrolides having immunosuppressive activity
US5252732A (en) * 1991-09-09 1993-10-12 Merck & Co., Inc. D-heteroaryl, O-alkylheteroaryl, O-alkenylheteroaryl and O-alkynylheteroarylmacrolides having immunosuppressive activity
US5247076A (en) * 1991-09-09 1993-09-21 Merck & Co., Inc. Imidazolidyl macrolides having immunosuppressive activity
US5457194A (en) * 1993-03-17 1995-10-10 Abbott Laboratories Substituted aliphatic amine-containing macrocyclic immunomodulators
GB2308546B (en) * 1994-10-26 1999-06-02 Novartis Ag Topical macrolide compositions

Also Published As

Publication number Publication date
KR19980703583A (ko) 1998-11-05
NO974536L (no) 1997-10-01
NO974536D0 (no) 1997-10-01
IL117815A (en) 2000-07-16
HUP9801993A2 (hu) 1998-12-28
IL117815A0 (en) 1996-08-04
NZ307170A (en) 1999-03-29
CZ312397A3 (cs) 1998-01-14
TR199700999T1 (xx) 1998-01-21
AU703523B2 (en) 1999-03-25
CO4750668A1 (es) 1999-03-31
MX9707636A (es) 1998-06-30
FI973529A0 (fi) 1997-08-27
AU5645396A (en) 1996-10-23
AR004480A1 (es) 1998-12-16
FI973529A (fi) 1997-11-25
HUP9801993A3 (en) 2000-04-28
SK133997A3 (en) 1998-05-06
CA2216562A1 (en) 1996-10-10
PL322553A1 (en) 1998-02-02
EP0819130A1 (en) 1998-01-21
US5925649A (en) 1999-07-20
NO309273B1 (no) 2001-01-08
WO1996031514A1 (en) 1996-10-10
JP2000505044A (ja) 2000-04-25
CN1180359A (zh) 1998-04-29
CN1088068C (zh) 2002-07-24

Similar Documents

Publication Publication Date Title
DE29513388U1 (de) Werkzeugkassette
DE59602881D1 (de) Sollwertgeber
BR9604808A (pt) Ascomicinas
ATA135896A (de) Skibob
DE29520966U1 (de) Bauelement
ATE198470T1 (de) Alkenyl-benzoylguanidine
DE29519675U1 (de) Bauelement
DE29516612U1 (de) Werkzeugkasten
KR970016473U (ko) 바이스
KR970000659U (ko) 바이스
ATE240972T1 (de) Cyclopeptolide
KR960036887U (ko) 화물 자동차용 작업대
DE29502574U1 (de) Werkzeugkasten
DE29517931U1 (de) Handwerkszeug
DK0803017T3 (da) Byggeelement
KR960033691U (ko) 네갈내 바이스
DE29521255U1 (de) Bauelement
DE29514597U1 (de) Bauelement
DE29516187U1 (de) Bauelement
DE29518666U1 (de) Bauelement
KR960033742U (ko) 공구상자
KR960034809U (ko) 공구상자
KR970028001U (ko) 공구박스
NO955137D0 (no) Kombinasjons arbeidsbenk
DE29515804U1 (de) Werkbank-Kombination

Legal Events

Date Code Title Description
FB36 Technical and formal requirements: requirement - article 36 of industrial property law
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]